N Larsen1, C von der Brelie2,3, D Trick4, C H Riedel5, T Lindner5, J Madjidyar5, O Jansen5, M Synowitz2, C Flüh2. 1. From the Department of Radiology and Neuroradiology (N.L., C.H.R., T.L., J.M., O.J.) naomi.larsen@uksh.de. 2. Department of Neurosurgery (C.v.d.B., M.S., C.F.). 3. Department of Neurosurgery (C.v.d.B.), University Hospital Göttingen, Göttingen, Germany. 4. Institute of Pathology (D.T.), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany. 5. From the Department of Radiology and Neuroradiology (N.L., C.H.R., T.L., J.M., O.J.).
Abstract
BACKGROUND AND PURPOSE: Recent studies have suggested that wall enhancement of unruptured intracranial aneurysms in high-resolution MR imaging might serve as an imaging biomarker for higher risk of rupture. Histologic studies have revealed a possible association among inflammatory processes, degeneration, and destabilization of the aneurysm wall preceding rupture. Understanding the histologic condition underlying aneurysm wall enhancement could be an important step toward assessing the value of this method for risk stratification. We present our observations of aneurysm wall enhancement in MR vessel wall imaging and underlying histologic changes. MATERIALS AND METHODS: We reviewed records of patients with an unruptured middle cerebral artery aneurysm who underwent MR vessel wall imaging before aneurysm clipping. Contrast enhancement of the aneurysm wall was dichotomized into either none/faint or strong. Histologic analysis included myeloperoxidase stain for detection of inflammatory cell invasion and CD34 stain for assessment of neovascularization and vasa vasorum. RESULTS: Thirteen aneurysms were included. Five aneurysms showed strong wall enhancement. Among these, myeloperoxidase staining revealed inflammatory cell infiltration in 4. Three showed neovascularization. In 2 aneurysms, vasa vasorum were present. Seven aneurysms did not show wall enhancement; 1 had only mild enhancement. None of these bore evidence of inflammatory cell invasion or neovascularization, and they all lacked vasa vasorum. CONCLUSIONS: Wall enhancement in MR vessel wall imaging is associated with inflammatory cell invasion, neovascularization, and the presence of vasa vasorum. Enhancement does not occur when histologic signs of inflammation are absent. Our results support the hypothesis that MR vessel wall imaging could provide valuable information for risk stratification.
BACKGROUND AND PURPOSE: Recent studies have suggested that wall enhancement of unruptured intracranial aneurysms in high-resolution MR imaging might serve as an imaging biomarker for higher risk of rupture. Histologic studies have revealed a possible association among inflammatory processes, degeneration, and destabilization of the aneurysm wall preceding rupture. Understanding the histologic condition underlying aneurysm wall enhancement could be an important step toward assessing the value of this method for risk stratification. We present our observations of aneurysm wall enhancement in MR vessel wall imaging and underlying histologic changes. MATERIALS AND METHODS: We reviewed records of patients with an unruptured middle cerebral artery aneurysm who underwent MR vessel wall imaging before aneurysm clipping. Contrast enhancement of the aneurysm wall was dichotomized into either none/faint or strong. Histologic analysis included myeloperoxidase stain for detection of inflammatory cell invasion and CD34 stain for assessment of neovascularization and vasa vasorum. RESULTS: Thirteen aneurysms were included. Five aneurysms showed strong wall enhancement. Among these, myeloperoxidase staining revealed inflammatory cell infiltration in 4. Three showed neovascularization. In 2 aneurysms, vasa vasorum were present. Seven aneurysms did not show wall enhancement; 1 had only mild enhancement. None of these bore evidence of inflammatory cell invasion or neovascularization, and they all lacked vasa vasorum. CONCLUSIONS: Wall enhancement in MR vessel wall imaging is associated with inflammatory cell invasion, neovascularization, and the presence of vasa vasorum. Enhancement does not occur when histologic signs of inflammation are absent. Our results support the hypothesis that MR vessel wall imaging could provide valuable information for risk stratification.
Authors: Pervinder Bhogal; Joseph Lansley; Ken Wong; Sundip D Udani; Chris Uff; John Wadley; Atul Kumar; Charles C Matouk; Hegoda Ld Makalanda Journal: Interv Neuroradiol Date: 2019-02-14 Impact factor: 1.610
Authors: Jorge A Roa; Mario Zanaty; Carlos Osorno-Cruz; Daizo Ishii; Girish Bathla; Santiago Ortega-Gutierrez; David M Hasan; Edgar A Samaniego Journal: J Neurosurg Date: 2020-02-07 Impact factor: 5.115
Authors: Arianna Rustici; Elena Merli; Sabina Cevoli; Marco Di Donato; Giulia Pierangeli; Valentina Favoni; Carlo Bortolotti; Carmelo Sturiale; Pietro Cortelli; Luigi Cirillo Journal: Interv Neuroradiol Date: 2020-12-10 Impact factor: 1.610
Authors: Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener Journal: Front Immunol Date: 2021-06-24 Impact factor: 7.561
Authors: S Hadad; F Mut; B J Chung; J A Roa; A M Robertson; D M Hasan; E A Samaniego; J R Cebral Journal: AJNR Am J Neuroradiol Date: 2020-12-24 Impact factor: 3.825